Population pharmacokinetic analysis of pegylated human erythropoietin in rats

This publication has 11 references indexed in Scilit:

• Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates
  Advanced Drug Delivery Reviews, 2003
• Pharmacokinetic and Pharmacodynamic Modeling of Recombinant Human Erythropoietin after Intravenous and Subcutaneous Dose Administration in Cynomolgus Monkeys
  The Journal of Pharmacology and Experimental Therapeutics, 2003
• Effect of pegylation on pharmaceuticals
  Nature Reviews Drug Discovery, 2003
• Distinguishing animal subsets in toxicokinetic studies: comparison of non-linear mixed effects modelling with non-compartmental methods
  Journal of Applied Toxicology, 2002
• Fisher information matrix for non‐linear mixed‐effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics
  Statistics in Medicine, 2002
• Pegylation
  Clinical Pharmacokinetics, 2001
• The Role of Population Pharmacokinetics in Drug Development in Light of the Food and Drug Administration??s ???Guidance for Industry: Population Pharmacokinetics???
  Clinical Pharmacokinetics, 2000
• Use of Nonlinear Mixed Effect Modeling for the Meta‐Analysis of Preclinical Pharmacokinetic Data: Application to S 20342 in the Rat
  Journal of Pharmaceutical Sciences, 2000
• The Pharmacokinetic Principles Behind Scaling from Preclinical Results to Phase I Protocols
  Clinical Pharmacokinetics, 1999
• A General Model for the Origin of Allometric Scaling Laws in Biology
  Science, 1997